Nilotinib (AMN-107)

inquiry

Cat No.

CEI-0267

Description

Nilotinib (AMN-107) can inhibit Bcr-Abl with IC50 of 30 nM.

Alias

Tasigna

CAS_No

641571-10-0

Molecular Weight

529.52

Purity

>99%

Storage

2 years at -20centigrade Powder

Synonyms

Tasigna

Targets

Bcr-Abl

Molecular Formula

C28H22F3N7O

Chemical Name

4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)benzamide

Solubility

DMSO 36 mg/mL Water

In vitro

Nilotinib(AMN-107) is a novel tyrosine kinase inhibitor targeting KIT (CD117), PDGFR and BCR-ABL and inhibiting the proliferation of both imatinib-sensitive and imatinib-resistant cells in vitro. AMN-107, which is more potent than imatinib, can inhibit the proliferation of haematopoietic cells expressing the mutants in Ph+ CML and acute lymphoblastic leukaemia with IC50 of 12 nM, approximately. For several imatinib-resistant Bcr-Abl mutants expect T3151, AMN-107 can effective against them.

In vivo

In mice transduced with Bcr-Abl, AMN-107 reduced mortality and tumour burden. In mice transduced with the E255V imatinib-resistant mutant of Bcr-Abl, AMN-107 delayed the onset of leukaemia.

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry